Fractyl Health, Inc. (GUTS)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Biotechnology (Startups)	93.00K	120.00K	-	-
Biotechnology (Startups) Growth	-22.50%	-	-	-
Total	93.00K	120.00K	-	-
Total Growth	-22.50%	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
United States	93.00K	120.00K	-	-
United States Growth	-22.50%	-	-	-
Total	93.00K	120.00K	-	-
Total Growth	-22.50%	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 13, 2026

Data Sources Report a data error